PND

Is Transcranial Magnetic Stimulation Effective for Postpartum Depression?

Transcranial magnetic stimulation (TMS), an FDA approved treatment for major depression, is a noninvasive procedure which uses magnetic fields to stimulate specific areas of the brain. It is not commonly used as a first [...]

By |2020-07-09T13:37:28-04:00March 18th, 2020|Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on Is Transcranial Magnetic Stimulation Effective for Postpartum Depression?

If We Are So Concerned About Maternal Mental Health, Why Don’t We Have More Mother-Baby Mental Health Programs? 

The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, [...]

By |2020-07-24T11:10:33-04:00January 15th, 2020|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on If We Are So Concerned About Maternal Mental Health, Why Don’t We Have More Mother-Baby Mental Health Programs? 

Don’t Forget About Brexanolone’s Little Sister: Zuranolone

While we have been talking about using brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant - SAGE 217 or zuranolone - has [...]

By |2026-03-10T12:50:16-04:00January 7th, 2020|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Don’t Forget About Brexanolone’s Little Sister: Zuranolone

In Brief:  Postpartum Depression Common in First-Time Fathers

Depressive symptoms were assessed in a group of 622 Canadian first-time fathers during their partner’s third trimester using the Edinburgh Postnatal Depression Scale (EPDS).  The prevalence of depressive symptoms in fathers was 13.76% at 2 [...]

By |2019-12-21T17:06:32-04:00December 23rd, 2019|Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on In Brief:  Postpartum Depression Common in First-Time Fathers

Bonding Problems Emerge Early and Persist Across the First Year of Life

A mother’s emotional relationship with her baby begins during her pregnancy.  After her baby is born, the mother’s feelings about her baby, described as bonding, typically grow and intensify and become the foundation of the [...]

By |2019-12-10T16:31:14-04:00December 11th, 2019|Postpartum Psychiatric Disorders|Comments Off on Bonding Problems Emerge Early and Persist Across the First Year of Life

FDA Supports Intravenous Brexanolone for Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression (PPD).  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  Since that time, Sage Therapeutics [...]

By |2018-11-10T10:02:56-04:00November 10th, 2018|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on FDA Supports Intravenous Brexanolone for Postpartum Depression

After Stillbirth Women Are at Increased Risk for Depression

In the United States, about one out of every 160 pregnancies ends in stillbirth, defined as a pregnancy loss occurring after 20 weeks' gestation.  Perinatal loss is a traumatic event for women and their families. [...]

By |2020-01-13T21:33:54-04:00July 11th, 2018|Depressive Disorders, Infertility and Mental Health, Postpartum Psychiatric Disorders, Pregnancy Loss, Psychiatric Disorders During Pregnancy|Comments Off on After Stillbirth Women Are at Increased Risk for Depression

In Brief: ACOG Recommends Increased Level of Care During the “Fourth Trimester”

The American College of Obstetricians and Gynecologists (ACOG) has made a significant change to its recommendations for optimal postpartum care.  Previously, ACOG has recommended that women receive a single, comprehensive postpartum visit within the first [...]

By |2018-09-10T12:34:21-04:00April 30th, 2018|Postpartum Psychiatric Disorders|Comments Off on In Brief: ACOG Recommends Increased Level of Care During the “Fourth Trimester”

Postpartum Depression: Focus on Managing Comorbid Anxiety Symptoms

  Multiple studies have demonstrated the effectiveness of antidepressant medications for the treatment of postpartum depression (PPD).  Most of the these studies focused on the impact of these medications on depressive symptoms; however, it is [...]

By |2020-11-26T08:33:30-04:00September 20th, 2016|Postpartum Depression, Postpartum Psychiatric Disorders|Comments Off on Postpartum Depression: Focus on Managing Comorbid Anxiety Symptoms
Go to Top